Related Experiment Video
Updated: Jun 21, 2026
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
[Skin sparing mastectomy: a revisited technique]
Hala Rami1, Marwan Nasr, Joe Suidan
1Service de Gynécologie-Obstétrique, CHU Hôtel-Dieu de France, Beyrouth, Liban.
Summary
Skin-sparing mastectomy (SSM) offers oncological safety and improved aesthetics for early-stage breast cancer. This breast conservation technique involves mastectomy with immediate reconstruction, showing comparable outcomes to traditional methods.
Area of Science:
- Surgical Oncology
- Breast Cancer Treatment
- Plastic and Reconstructive Surgery
Context:
- Skin-sparing mastectomy (SSM) is an innovative surgical approach for early-stage breast carcinoma.
- The technique involves total mastectomy while preserving the breast's skin envelope, often using a periareolar incision.
- Immediate reconstruction with prostheses or flaps follows the mastectomy.
Purpose:
- To review the current literature on skin-sparing mastectomy (SSM) as a treatment option for breast cancer.
- To evaluate the oncological safety, aesthetic outcomes, and patient satisfaction associated with SSM.
- To discuss the limitations and controversies surrounding SSM, particularly in advanced breast cancer stages.
Summary:
- SSM involves mastectomy with preservation of the skin envelope and immediate reconstruction.
- Postoperative concerns include flap necrosis and reconstruction complications.
- Oncological outcomes (relapse, metastasis, survival) are comparable to non-SSM procedures.
- The technique is controversial for advanced breast cancer (stages 2B and 3).
Impact:
- SSM demonstrates oncological safety, with no significant differences in relapse, metastasis, or survival rates compared to conventional mastectomy.
- The procedure is associated with high levels of patient and surgeon satisfaction due to improved aesthetic results.
- While effective for early-stage disease, its application in advanced breast cancer remains a subject of debate.
